Clinical Trials · NCT02041195
Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Enrollment
- 99
- Start date
- Jan 2014
- Locations
- 2 sites, United States
- Primary endpoint
- Body Weight - Stage A